Skip to main content
SpringerLink
Log in

12 versus 6 cycles of adjuvant CMF in breast cancer

  • Correspondence
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Surgical Unit B', Evangelismos Hospital, Athens, Greece

    Anaxagoras Papaioannou M.D. & George Papageorgiou M.D.

Authors
  1. Anaxagoras Papaioannou M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Papageorgiou M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papaioannou, A., Papageorgiou, G. 12 versus 6 cycles of adjuvant CMF in breast cancer. Breast Cancer Res Tr 2, 411 (1982). https://doi.org/10.1007/BF01805885

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01805885

Keywords

Search

Navigation